Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer plasticity allows tumor cells to change their identity, evade therapies, and adapt to environmental pressures, contributing to treatment resistance and metastasis. New research is targeting this adaptability through epigenetic drugs, immune checkpoint inhibitors, and strategies to limit phenotypic switching.

The Cancer Cell Surface Proteome as a Therapeutic Target

Living with Cancer Pain

Caring for a Loved One with Cancer

Hot vs Cold: the differences between tumor types

The Biochemistry of Breast Cancer Screening

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Using Biomarkers to Detect Cancer

Overview of Cell Viability and Cytotoxicity

What is Cancer?

Metastatic Migration in Cancer may be Influenced by Metabolism

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

See more featured articles »

Secondary Lung Cancer

Cancer Prevention: Lowering your Risk

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

TARDIS: The Improved Method of Detecting Breast Cancer

Secondary Brain Cancer

Cancer Glossary

Targeted Cancer Therapies

Cancer Pathophysiology

Cancer Pain

What is the Tumor Microenvironment?

Cutaneous Manifestations of Internal Malignancy

Cancer Management

Pediatric Cancer

What is Immunochemotherapy?

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Insight into Cancer Vaccines

The Effects of Cancer on Family Life

CDK9 and Cancer

Cancer Pain Management

British Pioneers in Cancer Biology

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

What is Cancer of Unknown Primary?

Cancer Prognosis

Why are Cancer Cell Lines Useful?

Cancer Screening Considerations: Balancing the Benefits and Risks

What is Tumorigenesis?

Transforming Cancer Care through Genomic Testing

What is Merkel Cell Carcinoma?

Investigating the Molecular Mechanisms of Cancer

Exploiting Enzymes in Cancer Diagnosis and Therapy

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Is Cancer a Metabolic Disorder?

What Role do Biobanks Play in Cancer Research?

Cancer Classification

Cancer Epidemiology

Acidosis and Tumor Progression

Assay for Monitoring and Treating Malignant Brain Tumors

Hypoxia Markers and Their Importance

Effects of Social and Economic Deprivation on Cancer Mortality

Cancer Symptoms

Cancer History

Microfluidic cancer treatment screen combined with flow cytometry

What Causes Cancer?

Insights into Oncofertility

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Diagnosis

Cancer Research

Myc Mutations and Cancer

Latest Cancer News and Research

In RFK Jr.’s upside-down world of vaccines, panel votes to end hepatitis B shot at birth

Recent weeks have brought good news about vaccines, with studies indicating that flu vaccination reduces heart disease, shingles vaccines can prevent or slow dementia, and a single human papilloma virus shot protects a girl from cervical cancer for the rest of her life.

5 Dec 2025

Protein network locks ABCC4 transporters in place to maintain cyclic AMP signaling levels

When a cell receives a message from outside, it generates a molecule called cyclic AMP (cAMP) to relay this message. To ensure the signal reaches the correct effector without triggering pathways accidentally, cAMP levels must be maintained around their point of origin and at the right level.

5 Dec 2025

Most Americans still back early hepatitis B vaccination despite policy debate

On December 5, 2025, the Trump administration's Advisory Committee on Immunization Practices (ACIP), whose members were handpicked by Health and Human Services (HHS) Secretary and vaccination critic Robert F. Kennedy Jr., is scheduled to determine whether it should recommend that the Centers for Disease Control and Prevention (CDC) change the recommendation in place since 1991 that newborns be vaccinated against hepatitis B.

5 Dec 2025

$New targeted alpha therapy shows promise for patients with radioiodine-refractory thyroid cancer$

New targeted alpha therapy shows promise for patients with radioiodine-refractory thyroid cancer

A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, investigators found that a single dose of the alpha-emitting radionuclide 211At (astatine) was both well-tolerated and effective, achieving disease control without molecularly targeted drugs.

5 Dec 2025

New atomic structure reveals how NBCn1 transporter protein aids breast cancer cell survival

UCLA scientists have characterized the structure and function of a key survival protein in breast cancer cells that helps explain how these tumors resist environmental stress and thrive in acidic, low-oxygen environments that would normally be toxic to healthy cells.

5 Dec 2025

Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with targeted therapies.

5 Dec 2025

New combination treatment helps people with recurring grade 3 astrocytoma, trial shows

Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an aggressive form of brain cancer, live longer.

5 Dec 2025

Study shines light on how P2X4 receptor can be inhibited

A study carried out by the University of Bonn and the University Hospital Bonn throws light on how an important receptor can be inhibited.

5 Dec 2025

Higher PFAS levels reduce blood sugar improvements after teen bariatric surgery

A new USC study shows teens with higher blood levels of per- and polyfluoroalkyl substances (PFAS) measured before bariatric surgery had smaller improvements in blood sugar over five years, including fasting glucose and hemoglobin A1c (HbA1c), which measures average blood sugar levels over the past 60-90 days.

4 Dec 2025

Bacterial enzyme linked to heart complications in pneumonia

Pneumonia is a disease that burdens the healthcare system with more that 1.2 million emergency room visits each year and more than 41,000 adult deaths in the United States.

4 Dec 2025

Engineered herpes virus activates potent immune responses against glioblastoma

Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells.

4 Dec 2025

Urine cfDNA patterns emerge as a promising tool for diagnosing bladder cancer

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, offering a much-needed alternative to invasive procedures like cystoscopies.

4 Dec 2025

Scientists uncover why SETX-deficient cancer cells rely on error-prone DNA repair

The DNA inside our cells is constantly being damaged, and one of the worst kinds of damage is a double-strand break-when both sides of the DNA helix are cut at once.

4 Dec 2025

Study uncovers strategy to sensitize estrogen receptor–positive breast tumors to immunotherapy

A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common tumor type, estrogen receptor-positive or luminal breast cancer.

4 Dec 2025

Remote group cognitive rehab shows promise for easing chemobrain in cancer survivors

A new study examined CRAFT-G, a remote group intervention combining cognitive training, psychoeducation, and occupational-therapy-based strategies for adults experiencing cancer-related cognitive impairment.

4 Dec 2025

Organ-on-a-chip system reveals how aging weakens vaccine-driven anti-cancer immunity

Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating cancer vaccine performance in older adults, the population most affected by cancer and often overlooked in traditional preclinical testing.

4 Dec 2025